Table of Contents
Volume 5 | Issue 7
Publication Date: December 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
420-421 |
Survival Analyses Overview in Hormone-Refractory Prostate Cancer Clinical Trials in the Prostate-Specific Antigen Era Oliver Sartor |
|
Comprehensive Review | ||
422-426 |
Inhibition of DNA Methylation by Antisense Oligonucleotide MG98 as Cancer Therapy Robert J. Amato |
|
Original Contributions | ||
427-432 |
Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial John D. Hainsworth, David R. Spigel, Jeffrey A. Sosman, Howard A. Burris III, Cindy Farley, Heather Cucullu, Kathleen Yost, Lowell L. Hart, Linda Sylvester, David M. Waterhouse, F. Anthony Greco |
|
433-437 |
The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial Karen G. Chee, Jeff Longmate, David I. Quinn, Gurkamal Chatta, Jacek Pinski, Przemyslaw Twardowski, Chong-Xian Pan, Angelo Cambio, Christopher P. Evans, David R. Gandara, Primo N. Lara Jr |
|
438-445 |
Characteristics of Synchronous- and Metachronous-Type Multiple Primary Neoplasms: A Study of Hospital-Based Cancer Registry in Turkey Sevil Kilciksiz, Tumay Gokce, Ali Baloglu, Aylin Callı, Canan Kaynak, Bülent Kilic, Erkan Eski, Gülten Nalbantoglu, Hacer Ari Yigitbas |
|
Case Reports | ||
446-451 |
Prolonged Complete Responses and Near-Complete Responses to Sunitinib in Metastatic Renal Cell Carcinoma Daniel Y. C. Heng, Brian I. Rini, Jorge Garcia, Laura Wood, Ronald M. Bukowski |
|
452-454 |
Sarcomatoid Collecting-Duct Carcinoma of the Kidney Slim Charfi, Lobna Ayadi, Sameh Ellouze, Abdelmajid Khabir, Imen Chtourou, Naourez Gouiaa, Ibticem Bahri, Tahya Sellami-Boudawara |
|
455-456 |
A New Case of Signet Ring Cell Carcinoma of the Prostate Amine Derouiche, Akrem Ouni, Nadia Kourda, Karim Belhadj, Sarra Ben Jilani, Mohamed Chebil |
|
Current Trials | ||
457-459 |
Phase II Study of Azacitidine to Restore Responsiveness of Prostate Cancer to Hormonal Therapy Guru Sonpavde, Ana Aparicio, Israel Guttierez, Kristi A. Boehm, Thomas E. Hutson, William R. Berry, Lina Asmar, Daniel D. von Hoff |
|
460-463 |
Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Maintenance Sunitinib Versus Placebo After Chemotherapy for Patients with Advanced Urothelial Carcinoma: Scientific Rationale and Study Design Deborah A. Bradley, Rodney Dunn, David Nanus, Walter Stadler, Robert Dreicer, Jonathan Rosenberg, David C. Smith, Maha Hussain |
|
Clinical Trials | ||
464-465 |
Selected Clinical Trials in Renal Cell Carcinoma and Prostate Cancer CIG Media Group |
|